The Clonal Analysis of Effector Mechanism in Graft Rejection

移植物排斥效应机制的克隆分析

基本信息

  • 批准号:
    01570710
  • 负责人:
  • 金额:
    $ 1.28万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)
  • 财政年份:
    1989
  • 资助国家:
    日本
  • 起止时间:
    1989 至 1990
  • 项目状态:
    已结题

项目摘要

Limiting Dilution Analysis (LDA) is a quantitative method with a high degree of accuracy and an indispensable way for the elucidation of rejection mechanism and tolerance. It is possible to estimate the absolute clonal size of Tcp (T cytotoxic precursor) by calculating the frequency of Tcp[ f (Tcp)]. The experimental model is a heterotopic heart transplantation in rats. Buffalo (BUF : RT-1^b) rats were used as heart donors and Wistar-Furth (WFu : RT-1^u) rats as recipients. The spleen T cells of untreated rats had a f (Tcp) of 1:2343<plus-minus>591, but the f (Tcp) just before rejecti on increased up to 1/195<plus-minus>123 which was about 12 times as high as that of the untreated rats. However, the allografted WFu rats had a decreased f (Tcp) of 1 : 696<plus-minus>243 after graft rejection.Thus, the present study concentrated upon the f (Tcp) of graft infiltrating cells (GICs) on day 5 postgrafting during ongoing rejection. The GICs in an allograft showed a remarkably high f (Tcp) of … More 1 : 113 in comparison with a f (Tcp) of 1 : 8584 seen in an isograft. The number of GICs obtained from allografts was (2.1<plus-minus>1.1)x10^7/graft. This was ten times as many as that isolated from isografts. The FACS analysis of GICs-T revealed that the number of percentage in OX19^+ (T), OX8^+ (Tc/s) and W3/25^+ (Th) cells were 70.9%, 64.5% and 25.9%. respectively.On day 5 postgrafting, the f (Tcp)s of spleen and lymphnode T cells were 1 : 195<plus-minus>123, 1:731<plus-minus>81, respectively. However, the GICs had the highest f (Tcp) of 1:84<plus-minus>53. Therefore, about 1.2% (1/84) of GICs-T cells was the donor specific Tcp on day5 postgrafting during ongoing rejeOn the other hand, the GICs also had T cells which could suppress the proliferative response of Mixed Lymphocyte Culture (MLC) in a donor specific manner. We could make some clones from the GICs on day 5 transplantation. The surface markers of these clones were Ox19^+ (T), W3/25^+ (Th),OX8^- (Ts/c), and OX22^+ (LCA). These clones could suppress the MLC response in a donor specific manner.Therefore, it is suggested that there might be a regulation mechanism by the T cells which could suppress the unlimited proliferation of donor antigen specific Tc cells in the graft during ongoing rejection on day 5 postgrafting. Less
极限稀释分析(LDA)是一种高精度的定量方法,是阐明排斥机制和耐受性的重要手段。通过计算Tcp的频率[f (Tcp)],可以估计Tcp (T细胞毒性前体)的绝对克隆大小。实验模型为大鼠异位心脏移植。Buffalo (BUF: RT-1^b)大鼠作为心脏供体,Wistar-Furth (WFu: RT-1^u)大鼠作为受体。未处理大鼠脾脏T细胞的f (Tcp)为1:2343<±>591,而排斥前的f (Tcp)高达1/195<±>123,约为未处理大鼠的12倍。然而,同种异体移植的WFu大鼠在排斥反应后f (Tcp)降低了1∶696<正负>243。因此,本研究集中于移植后第5天持续排斥反应中移植物浸润细胞(GICs)的f (Tcp)。同种异体GICs的f (Tcp)比同种异体GICs的f (Tcp)高1∶113,而同种异体GICs的f (Tcp)比同种异体GICs的f (Tcp)高1∶8584。同种异体移植物获得的GICs数量为(2.1<±>1.1)x10^7/块。这是从等移植物中分离出来的10倍。对GICs-T进行FACS分析,OX19^+ (T)、OX8^+ (Tc/s)和W3/25^+ (Th)细胞的百分数分别为70.9%、64.5%和25.9%。分别。移植后第5天,脾脏和淋巴结T细胞的f (Tcp)s分别为1∶195<正负>123、1∶731<正负>81。然而,GICs的f (Tcp)最高,为1:84<正负>53。因此,在移植后第5天,大约1.2%(1/84)的GICs-T细胞是供体特异性的Tcp。另一方面,GICs也有能够以供体特异性的方式抑制混合淋巴细胞培养(MLC)增殖反应的T细胞。我们可以在移植的第5天从GICs中克隆出一些克隆体。这些无性系的表面标记为Ox19^+ (T)、W3/25^+ (Th)、OX8^- (Ts/c)和OX22^+ (LCA)。这些克隆能够以供体特异性的方式抑制MLC反应。因此,提示在移植后第5天的持续排斥反应中,可能存在T细胞抑制供体抗原特异性Tc细胞无限制增殖的调节机制。少

项目成果

期刊论文数量(10)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
T. Ito et al: "Frequency of T cytotoxic cells correlates with the immune status in organ allograft recipients." Transplant Proc. 21. 3282-5 (1989)
T. Ito 等人:“T 细胞毒性细胞的频率与器官同种异体移植受者的免疫状态相关。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
伊藤 寿記他6名: "ラット移植モデルにおける細胞傷害性T細胞の解析 ー2.限界希釈法によるラット細胞傷害性T前駆細胞頻度の測定ー" 日本移植学会誌.
伊藤久树等6人:“大鼠移植模型中细胞毒性T细胞的分析 - 2.通过有限稀释法测量大鼠细胞毒性T祖细胞频率”日本移植学会杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
伊藤 寿紀: "ラット心移殖における細胞傷害性T細胞の解析ー細胞傷害性T前駆細胞頻度からみた急性拒絶反応の制御機構ー" 大阪大学医学会雑誌. 42. 631-640 (1990)
伊藤俊树:“大鼠心脏移植中细胞毒性T细胞的分析——从细胞毒性T祖细胞频率的角度控制急性排斥反应的机制”大阪大学医学会杂志42。631-640(1990)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
T.Ito et.al: "Frequency of T cytotoxce cells correlates with the immune Atatus in organ allogroft recipients" Transplant.Proc.21. 3282-5 (1989)
T.Ito 等人:“T 细胞毒性细胞的频率与器官同种异体移植受者的免疫状态相关”Transplant.Proc.21。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
T. Ito: "Analysis of cytotoxic T cell in rat heart transplantation -Regulation mechanism of acute rejection estimated by frequency of cytotoxic T cell precursor-" Medical J. of Osaka Univ. 42. 631-40 (1990)
T.伊藤:“大鼠心脏移植中细胞毒性T细胞的分析-通过细胞毒性T细胞前体频率估计的急性排斥的调节机制-”大阪大学医学杂志。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SHIRAKURA Ryota其他文献

SHIRAKURA Ryota的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SHIRAKURA Ryota', 18)}}的其他基金

Downregulation of the NK cell activity on xenograft
异种移植物上 NK 细胞活性的下调
  • 批准号:
    15390414
  • 财政年份:
    2003
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
The strategy for inhibiting NK cell activity by gene technology
利用基因技术抑制NK细胞活性的策略
  • 批准号:
    12470273
  • 财政年份:
    2000
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
A study of molecular diagnosis and treatment for chronic cardiac allograft rejection.
慢性心脏同种异体移植排斥反应的分子诊断和治疗研究。
  • 批准号:
    10557122
  • 财政年份:
    1998
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
A study for the in vivo mechanism of transplantation tolerance using GFP transgenic mice
GFP转基因小鼠体内移植耐受机制研究
  • 批准号:
    10470274
  • 财政年份:
    1998
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
The study elucidating the molecular mechanisms underlying transplant vasculopathy
该研究阐明了移植血管病变的分子机制
  • 批准号:
    08457349
  • 财政年份:
    1996
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
ESTABLISHMENT OF IMMUNOSUPPRRESIVE METHOD FOR CLINICAL XENOTRANSPLANTATION
临床异种移植免疫抑制方法的建立
  • 批准号:
    06454400
  • 财政年份:
    1994
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
The development of xenograft
异种移植的发展
  • 批准号:
    05557065
  • 财政年份:
    1993
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Developmental Scientific Research (B)

相似海外基金

Safety and efficacy of Belatacept in heart transplantation
贝拉西普在心脏移植中的安全性和有效性
  • 批准号:
    10622240
  • 财政年份:
    2023
  • 资助金额:
    $ 1.28万
  • 项目类别:
Targeted immune therapies in heart transplantation
心脏移植中的靶向免疫治疗
  • 批准号:
    10573846
  • 财政年份:
    2023
  • 资助金额:
    $ 1.28万
  • 项目类别:
Developing Machine Learning Models for Decision Support and Allocation Optimization in Heart Transplantation
开发用于心脏移植决策支持和分配优化的机器学习模型
  • 批准号:
    10735348
  • 财政年份:
    2023
  • 资助金额:
    $ 1.28万
  • 项目类别:
Dissecting the Role of Donor CCR2- Macrophages During Acute Cellular Rejection After Heart Transplantation
剖析供体 CCR2-巨噬细胞在心脏移植后急性细胞排斥过程中的作用
  • 批准号:
    10449753
  • 财政年份:
    2022
  • 资助金额:
    $ 1.28万
  • 项目类别:
Immunoregulatory Mechanisms of IL-33 in Heart Transplantation
IL-33在心脏移植中的免疫调节机制
  • 批准号:
    10680570
  • 财政年份:
    2022
  • 资助金额:
    $ 1.28万
  • 项目类别:
Dissecting the Role of Donor CCR2- Macrophages During Acute Cellular Rejection After Heart Transplantation
剖析供体 CCR2-巨噬细胞在心脏移植后急性细胞排斥过程中的作用
  • 批准号:
    10597230
  • 财政年份:
    2022
  • 资助金额:
    $ 1.28万
  • 项目类别:
Narrowing the gap between supply and demand in heart transplantation
缩小心脏移植供需差距
  • 批准号:
    10396268
  • 财政年份:
    2022
  • 资助金额:
    $ 1.28万
  • 项目类别:
Multiparametric Cardiac Positron Emission Tomography for Cardiac Allograft Vasculopathy Surveillance After Heart Transplantation: MARINER Trial
多参数心脏正电子发射断层扫描用于心脏移植后心脏同种异体移植血管病变监测:MARINER 试验
  • 批准号:
    469893
  • 财政年份:
    2022
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Operating Grants
Immunogenetic Profiling for Risk of Primary Graft Dysfunction after Heart Transplantation
心脏移植后原发性移植物功能障碍风险的免疫遗传学分析
  • 批准号:
    10391731
  • 财政年份:
    2021
  • 资助金额:
    $ 1.28万
  • 项目类别:
Immunogenetic Profiling for Risk of Primary Graft Dysfunction after Heart Transplantation
心脏移植后原发性移植物功能障碍风险的免疫遗传学分析
  • 批准号:
    10515335
  • 财政年份:
    2021
  • 资助金额:
    $ 1.28万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了